Last reviewed · How we verify

NCT07417930: ezParent FT

Hybrid Delivery to Increase Access and Sustainability: Evaluating ezParent Implementation

Not yet recruiting NA Last updated 27 February 2026
What this trial tests

NA trial testing ezParent in Parenting in 516 participants. Not yet recruiting.

Timeline
1 August 2026
Primary endpoint
30 September 2028
30 September 2028

Quick facts

Lead sponsorKlein Buendel, Inc.
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment516
Start date1 August 2026
Primary completion30 September 2028
Estimated completion30 September 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Klein Buendel, Inc. — full company profile →

Who can join

18 and older, any sex, with Parenting or Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to evaluate the effects of the hybrid ezParent program (e.g., web-based training program plus synchronous group sessions) on parent and child outcomes in a community setting serving parents of children 2-5 years old. Parent participants will complete surveys at baseline, and 10 and 24-weeks post baseline.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ezParent

Trials testing the same drug.

Other recruiting trials for Parenting

Currently open trials in the same condition.

Other Klein Buendel, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07417930.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing